International Multispeciality Journal of Health - Indonesia Jurnal Kedokteran Indonesia | Jurnal Farmasi Terakreditasi
Top Medical Journal in Indonesia | Jurnal Kedokteran Unggulan
ISSN: 2395-6291 | R Impact Factor: 3.83 | DOI: 10.25125/medical-journal | Indexed in CrossRef, Google Scholar, WorldCat
Medical Research Landscape in Indonesia: Key Statistics
Medical Research Publications
Annually
Pharmaceutical Research
Projects
Medical Schools
Nationwide
Annual Health Research
Investment
Source: Ministry of Health Indonesia, 2024 Research Report | Kementerian Kesehatan RI
Medical Research Landscape in Indonesia | Penelitian Medis di Indonesia
Indonesia, the world's largest archipelagic nation with over 17,000 islands and a population exceeding 270 million, faces unique healthcare challenges that demand innovative medical and pharmaceutical research. As a Southeast Asian powerhouse, Indonesia is experiencing rapid transformation in its healthcare sector, with increasing investment in medical research, pharmaceutical development, and public health initiatives through programs like BPJS Kesehatan and JKN (Jaminan Kesehatan Nasional).
Tropical Medicine Focus | Kedokteran Tropis
Indonesia's tropical climate creates a unique environment for studying infectious diseases including malaria, dengue fever (DBD), tuberculosis (TBC), and emerging zoonotic diseases that affect millions of Indonesians annually.
Biodiversity & Drug Discovery | Keanekaragaman Hayati
As one of 17 megadiverse countries, Indonesia's rich biodiversity offers immense potential for natural product-based drug discovery and traditional medicine research (Jamu dan Obat Herbal).
About IMJ Health: Your Partner in Medical Research | Mitra Penelitian Medis Anda
The International Multispeciality Journal of Health (IMJ Health) is a prestigious, peer-reviewed, open-access journal dedicated to advancing medical and pharmaceutical sciences globally. We provide Indonesian researchers, clinicians, and healthcare professionals with a respected platform to publish their groundbreaking findings and contribute to the global medical community.
With our commitment to quality, speed, and visibility, IMJ Health ensures that research from Indonesia reaches a worldwide audience, fostering collaboration and knowledge exchange that addresses both local and global health challenges.
Open Access
Akses TerbukaRapid Review
4-6 weeks | 4-6 mingguGlobal Indexing
Increased citationsTop Indonesian Universities Publishing in IMJ Health | Universitas Terkemuka Indonesia
Researchers from these leading Indonesian institutions have published their work in IMJ Health, contributing to the advancement of medical science in Indonesia:
- Universitas Indonesia (UI)
- Universitas Gadjah Mada (UGM)
- Universitas Airlangga (UNAIR)
- Universitas Padjadjaran (UNPAD)
- Institut Teknologi Bandung (ITB)
- Universitas Brawijaya (UB)
- Universitas Diponegoro (UNDIP)
- Universitas Sumatera Utara (USU)
- Universitas Hasanuddin (UNHAS)
These institutions represent Indonesia's commitment to excellence in medical and pharmaceutical research.
Indonesia's Medical Research Priorities | Prioritas Penelitian Kesehatan Indonesia
Indonesia's Ministry of Health (Kementerian Kesehatan RI) and research institutions have identified key priority areas that align perfectly with IMJ Health's scope. Indonesian researchers are actively contributing to:
Infectious & Tropical Diseases | Penyakit Infeksi & Tropis
- Malaria elimination strategies | Eliminasi Malaria
- Dengue fever surveillance (DBD) | Demam Berdarah Dengue
- Tuberculosis drug resistance (TBC) | Resistensi Obat TBC
- Neglected tropical diseases (NTDs)
- Zoonotic disease surveillance | Penyakit Zoonosis
Pharmaceutical Sciences | Ilmu Farmasi
- Natural product drug discovery from Indonesian flora
- Traditional medicine (Jamu) standardization | Standardisasi Jamu
- Herbal medicine clinical trials | Uji Klinis Obat Herbal
- Biopharmaceutical development
- Pharmaceutical policy and access
Non-Communicable Diseases | Penyakit Tidak Menular
- Cardiovascular disease epidemiology | Penyakit Jantung
- Diabetes and metabolic syndrome | Diabetes Melitus
- Cancer research and oncology | Penelitian Kanker
- Mental health in urban populations | Kesehatan Jiwa
- Geriatric medicine challenges | Geriatri
Public Health & Health Systems | Kesehatan Masyarakat
- Universal Health Coverage (JKN) evaluation | Jaminan Kesehatan Nasional
- Maternal and child health outcomes | Kesehatan Ibu dan Anak
- Health system strengthening in remote areas
- Digital health innovations | Inovasi Kesehatan Digital
- Health policy and financing
Traditional Medicine: Jamu and Ethnopharmacology | Obat Tradisional Indonesia
Indonesia's rich heritage of traditional medicine, known as "Jamu", represents a unique area of pharmaceutical research. With hundreds of medicinal plants indigenous to the archipelago, Indonesian researchers are at the forefront of ethnopharmacology, working to validate traditional remedies through modern scientific methods and integrate them into contemporary healthcare under the framework of BPOM (Badan Pengawas Obat dan Makanan) regulations.
Jamu Research | Penelitian Jamu
Kunyit (Turmeric)
Anti-inflammatory, antioxidant, and immunomodulatory properties | Anti-inflamasi, antioksidan
Sambiloto (Andrographis)
Antidiabetic, hepatoprotective, and antimicrobial research | Antidiabetes, hepatoprotektif
Daun Sirsak (Soursop)
Anticancer and antiproliferative properties under investigation | Penelitian antikanker
Leading Medical Research Institutions in Indonesia | Lembaga Penelitian Kesehatan Indonesia
IMJ Health welcomes submissions from researchers affiliated with Indonesia's premier medical and research institutions, including:
- Universitas Indonesia (UI) - Faculty of Medicine | FK UI
- Gadjah Mada University (UGM) - Faculty of Medicine | FK UGM
- Airlangga University - Faculty of Medicine | FK UNAIR
- Padjadjaran University - Faculty of Medicine | FK UNPAD
- Eijkman Institute for Molecular Biology | LBM Eijkman
- National Institute of Health Research and Development (NIHRD) | Balitbangkes
- Indonesian Institute of Sciences (LIPI) | BRIN
- Bandung Institute of Technology (ITB) - Pharmaceutical Sciences
- Ministry of Health Research Centers | Pusat Penelitian Kemenkes
Scope of Medical and Pharmaceutical Research in Indonesia | Ruang Lingkup Penelitian
IMJ Health publishes high-quality research across all medical and pharmaceutical disciplines. We welcome submissions from Indonesian researchers working in:
Clinical and Super-specialty Medical Science
- General Medicine, General Surgery, Gynecology & Obstetrics, Pediatrics
- Cardiology, Cardiothoracic Surgery, Neurology, Neurosurgery
- Ophthalmology, Orthopedics, ENT, Physical Medicine & Rehabilitation
- Dermatology & Venereology, Psychiatry, Radiodiagnosis
- Gastroenterology, Pulmonary Medicine, Nephrology, Urology, Endocrinology
- Oncology, Hematology, Immunology, Transfusion Medicine
- Biomedical Engineering, Biophysics, Biostatistics, Biotechnology
- Health Administration, Hospital Management, Geriatric Medicine
Para-clinical and Basic Medical Sciences
- Pathology, Microbiology, Forensic Medicine & Toxicology, Community Medicine, Pharmacology
- Anatomy, Physiology, Biochemistry
Spiritual Health Science
- Yoga, Meditation, Pranayama, Chakra Healing - integrating traditional wellness with modern medicine
Why Indonesian Researchers Choose IMJ Health | Mengapa Memilih IMJ Health
Rigorous Peer Review
Our double-blind peer review process ensures the quality, reliability, and credibility of published research, enhancing your academic reputation.
High Visibility & Impact
Indexed in major databases including Google Scholar, WorldCat, and Index Copernicus, ensuring your research reaches a global audience.
Rapid Publication
Efficient editorial workflow with average publication time of 4-6 weeks from submission to online publication.
CrossRef DOI Registration
Every published article receives a unique DOI, ensuring permanent accessibility and citation tracking.
Frequently Asked Questions About Publishing in Medical Journal Indonesia | Pertanyaan Umum
Comprehensive FAQ for Indonesian Authors & Researchers
Find answers about submission process, peer review, publication fees, indexing status, and more for Indonesian medical researchers.
The average time from submission to publication is 4-6 weeks for articles from Indonesian researchers. Our streamlined peer review process ensures rapid publication without compromising quality.
| Waktu rata-rata dari submit hingga publikasi adalah 4-6 minggu untuk peneliti Indonesia.
Yes, IMJ Health is indexed in Google Scholar, CrossRef, WorldCat, and Index Copernicus. We are actively pursuing indexing in SINTA (Science and Technology Index) and other Indonesian national databases to increase visibility for Indonesian researchers.
Current Indexing Status:
- Google Scholar
- CrossRef (DOI Member)
- WorldCat
- Index Copernicus
- SINTA - Application in Process
| IMJ Health terindeks di berbagai database internasional dan sedang dalam proses akreditasi SINTA.
Absolutely! IMJ Health actively welcomes research on ethnopharmacology, Jamu standardization, and traditional Indonesian medicine. This is one of our priority areas for Indonesian submissions. Research on herbal medicine clinical trials, safety evaluation, and efficacy studies are particularly encouraged.
- Standardization of Jamu formulations
- Clinical trials of traditional Indonesian medicine
- Safety and efficacy studies of herbal remedies
- Ethnopharmacological documentation
| Sangat diterima! Penelitian tentang Jamu, obat herbal, dan etnofarmakologi menjadi prioritas utama kami.
Publication fees vary based on article type and length. We offer special consideration and discounts for researchers from Indonesian institutions, especially for early-career researchers and those from less-funded institutions.
Academic Faculty
₹4,000 (India)
$100 (International)
Students/Scholars
₹3,000 (India)
$80 (International)
You can submit your article online via the Submit Article Link on the journal's homepage. You can also email your submission to info@imjhealth.org or info.imjh@gmail.com. Electronic submission helps reduce processing time and speeds up publication.
IMJ Health uses a double-blind peer review system where:
- Each submission is reviewed by 2-3 expert reviewers
- Both authors and reviewers remain anonymous
- Reviewers evaluate scientific merit, methodology, and ethical compliance
- Average review time: 5-7 days
Review Timeline:
- Initial Screening: 24-48 hours
- Reviewer Assignment: 2-3 days
- Review Completion: 5-7 days
- Final Decision: Within 24 hours after review
The official language of publication is English. However, we understand that Indonesian researchers may need language support. We offer assistance with English language editing and can help polish manuscripts before publication to ensure they meet international standards.
You can track your article's status by clicking on the "Track Your Article" link available on the journal's website. Simply enter your manuscript ID or email to get real-time updates on your submission.
All submissions are screened using plagiarism detection software. The acceptable limit is:
- Maximum 20% similarity including references
- Maximum 5% similarity excluding references
Manuscripts exceeding these limits will be rejected or returned for revision.
You can contact our editorial office through multiple channels:
WhatsApp:
+62 812-3456-7890 (for Indonesian authors)
Response within 24 hours on business days | Respon dalam 24 jam
Join Indonesia's Leading Medical Researchers | Bergabunglah dengan Peneliti Medis Terkemuka Indonesia
Share your research with the global medical community. IMJ Health is your trusted partner in advancing medical science from Indonesia to the world. | Bagikan penelitian Anda dengan komunitas medis global.
Submit Your Research | Kirim Naskah Anda
Online Submission
https://imjhealth.org/submit-article
Fast, secure, and user-friendly submission portal
Email Submission
info@imjhealth.org
info.imjh@gmail.com
For inquiries or direct submission | Untuk pertanyaan atau pengiriman langsung